 

#  University of Pittsburgh Secures $1m NIH Grant for Collaboration with Tiba Biotech Developing RNA-based COVID-19 Vaccine 

 





June 08, 2020

 

 

Founded in 2016, this pre-clinical stage biotechnology company seeks to revolutionize the design and delivery of a safer, more effective and affordable generation of nucleic acid products for human and animal health. The company positions that its RNA vaccine platform disrupts existing design, delivery and bio-manufacturing processes while enabling the rapid development of highly effective vaccines against multiple diseases. [Read more -&gt;](https://www.trialsitenews.com/university-of-pittsburgh-secures-1m-nih-grant-for-collaboration-with-tiba-biotech-developing-rna-based-covid-19-vaccine/)

 

 

 



 

 

 Share on:- [     Facebook ](#)
- [     Twitter ](#)
- [     Linkedin ](#)